Status:
ACTIVE_NOT_RECRUITING
Digital Breast Tomosynthesis for the Dutch National Breast Cancer Screening Program
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Erasmus Medical Center
UMC Utrecht
Conditions:
Breast Cancer Screening
Eligibility:
FEMALE
50-72 years
Phase:
NA
Brief Summary
Digital breast tomosynthesis (DBT) creates a digital pseudo- three-dimensional image of the breast similar to mammography. This gives the screening radiologist more information about a possible abnorm...
Detailed Description
In the last decade, several large-scale European studies have shown that digital breast tomosynthesis (DBT) increases the detection rate from \~6 to \~9 cancers per 1000 women screened, while the reca...
Eligibility Criteria
Inclusion
- Women who are invited to participate to the Dutch Breast Cancer Screening program in the age group 50-72 years..
Exclusion
- Disabled women
- Women who are wheelchair bound
Key Trial Info
Start Date :
July 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
18200 Patients enrolled
Trial Details
Trial ID
NCT06059300
Start Date
July 17 2023
End Date
July 1 2028
Last Update
July 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bevolkingsonderzoek Nederland
Utrecht, Netherlands